India moves closer to dengue vaccine as final trials underway

An Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. Over 10,000 volunteers are participating in the trials. If successful, DengiAll could be available next year. This development is crucial for India and other lower-middle-income countries facing rising dengue cases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4RBklXJ
via IFTTT